参考文献/References:
[1]Siegel RL,Miller KD,Jemal A.Cancer statistics,2018[J].Ca A Cancer Journal for Clinicians,2018,68(1):7.[2]Niu C,Sun X,Zhang W,et al.NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer[J].International Journal of Molecular Sciences,2016,17(10):1694.[3]Deivendran S,Marzook KH,Radhakrishna Pillai M.The role of inflammation in cervical cancer[J].Adv Exp Med Biol,2014(816):377-399.[4]Zhang L,Su Y,Chen Z,et al.The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type Ⅱ/Ⅲ adenocarcinoma of esophagogastric junction[J].Medicine(Baltimore),2017,96(30):e7647.[5]Nazha B,Moussaly E,Zaarour M,et al.Hypoalbuminemia in colorectal cancer prognosis:Nutritional marker or inflammatory surrogate[J].World J Gastrointest Surg,2015,7(12):370-377.[6]Zheng RR,Huang M,Jin C,et al.Cervical cancer systemic inflammation score:a novel predictor of prognosis[J].Oncotarget,2016,7(12):15230-15242.[7]Templeton AJ,Ace O,McNamara MG,et al.Prognostic role of platelet to lymphocyte ratio in solid tumors:a systematic review and meta-analysis[J].Cancer Epidemiol Biomarkers Prev,2014,23(7):1204-1212.[8]Dolan RD,McSorley ST,Horgan PG,et al.The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer:Systematic review and meta-analysis[J].Crit Rev Oncol Hematol,2017(116):134-146.[9]Haraga J,Nakamura K,Omichi C,et al.Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy[J].Molecular and Clinical Oncology,2016(5):567-574.[10]Sun K,Chen S,Xu J,et al.The prognostic significance of the prognostic nutritional index in cancer:a systematic review and meta-analysis[J].Journal of Cancer Research and Clinical Oncology,2014,140(9):1537-1549.[11]Kinoshita A,Onoda H,Imai N,et al.The C-Reactive Protein/Albumin Ratio,a Novel Inflammation-Based Prognostic Score,Predicts Outcomes in Patients with Hepatocellular Carcinoma[J].Annals of Surgical Oncology,2015,22(3):803-810.[12]Zhou T,Zhan J,Hong S,et al.Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer[J].Scientific Reports,2015(5):10481.[13]Shibutani M,Maeda K,Nagahara H,et al.Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer[J].Anticancer Research,2016,36(3):995-1002.[14]Otowa Y,Nakamura T,Yamamoto M,et al.C-reactive protein to albumin ratio is a prognostic factor for patients with Stage /Ⅲ esophageal squamous cell cancer[J].Dis Esophagus,2017,30(12):1-5. [15]Stevens L,Pathak S,Nunes QM,et al.Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer:a systematic review[J].HPB(Oxford),2015,17(4):285-291.[16]Bodner-Adler B,Kimberger O,Schneidinger C,et al.Prognostic Significance of Pre-treatment Serum C-Reactive Protein Level in Patients with Adenocarcinoma of the Uterine Cervix[J].Anticancer Research,2016,36(9):4691-4696.[17]Polterauer S,Grimm C,Zeillinger R,et al.Association of C-Reactive Protein(CRP)Gene Polymorphisms,Serum CRP Levels and Cervical Cancer Prognosis[J].Anticancer Research,2011,31(6):2259-2264.[18]Kumar A,Jain M,Yadav A,et al.Pattern of mismatch repair protein loss and its clinicopathological correlation in colorectal cancer in North India[J].S Afr J Surg,2018,56(1):25-29.[19]Zimmerman MA,Selzman CH,Cothren C,et al.Diagnostic implications of C-reactive protein[J].Arch Surg,2003,138(2):220-224.[20]Friel G,Liu CS,Kolomeyevskaya NV,et al.Aspirin and Acetaminophen Use and the Risk of Cervical Cancer[J].Journal of Lower Genital Tract Disease,2015,19(3):189-193.[21]Hindler K,Cleeland CS,Rivera E,et al.The role of statins in cancer therapy[J].Oncologist,2006,11(3):306-315. [22]Trikha M,Corringham R,Klein B,et al.Targeted anti-interleukin-6 monoclonal antibody therapy for cancer:a review of the rationale and clinical evidence[J].Clin Cancer Res,2003,9(13):4653-4665.
相似文献/References:
[1]廖加群,曹 雪,陈燕平,等.宫颈癌盆腔淋巴结转移分布及危险因素分析[J].医学信息,2018,31(03):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
LIAO Jia-qun,CAO Xue,CHEN Yan-ping,et al.Distribution and Risk Factors of Pelvic Lymph Node Metastasis in Cervical Cancer[J].Medical Information,2018,31(08):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
[2]徐 洁.宫颈癌筛查及预防的研究进展[J].医学信息,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
XU Jie.Advances in Screening and Prevention of Cervical Cancer[J].Medical Information,2018,31(08):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
[3]蔡亚磊,邓思雨,杨 健.宫颈癌放疗增敏的研究现状[J].医学信息,2022,35(09):65.[doi:10.3969/j.issn.1006-1959.2022.09.016]
CAI Ya-lei,DENG Si-yu,YANG Jian.Research Status of Radiotherapy Sensitization for Cervical Cancer[J].Medical Information,2022,35(08):65.[doi:10.3969/j.issn.1006-1959.2022.09.016]
[4]车 莹.HPV感染与宫颈病变相关性的研究[J].医学信息,2022,35(09):84.[doi:10.3969/j.issn.1006-1959.2022.09.021]
CHE Ying.Study on the Correlation Between HPV Infection and Cervical Lesions[J].Medical Information,2022,35(08):84.[doi:10.3969/j.issn.1006-1959.2022.09.021]
[5]曹 亮,郝 朋,李阳明,等.宫颈癌所致输尿管梗阻患者输尿管支架置入成功率影响因素的Meta分析[J].医学信息,2022,35(09):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
CAO Liang,HAO Peng,LI Yang-ming,et al.Meta Analysis of Factors Influencing Success Rate of Ureteral Stent Implantation in Patients with Ureteral Obstruction Caused by Cervical Cancer[J].Medical Information,2022,35(08):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
[6]覃念群,刘 楷,米镜霖,等.基于生物信息学分析筛选与宫颈癌预后相关的关键基因[J].医学信息,2022,35(10):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
QIN Nian-qun,LIU Kai,MI Jing-lin,et al.Screening Key Genes Related to the Prognosis of Cervical Cancer Based on Bioinformatics Analysis[J].Medical Information,2022,35(08):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
[7]黄 花,徐冬冬,章丽霞.TGF-β1在宫颈癌中的研究进展[J].医学信息,2018,31(12):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
HUANG Hua,XU Dong-dong,ZHANG Li-xia.Research Progress of TGF-β1 in Cervical Cancer[J].Medical Information,2018,31(08):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
[8]夏易曼娜,李虎成.腹腔镜下宫颈癌根治术与传统开腹手术的对比研究[J].医学信息,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
XIA Yi-manna,LI Hu-cheng.Comparative Study of Laparoscopic Radical Resection of Cervical Cancer and Traditional Open Surgery[J].Medical Information,2018,31(08):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
[9]杨 军,王翠平,李 龙,等.义安区体检HPV-DNA筛查结果分析[J].医学信息,2018,31(14):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
YANG Jun,WANG Cui-ping,LI Long,et al.Analysis of the Results of HPV-DNA Screening in the Medical Examination of Yian District[J].Medical Information,2018,31(08):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
[10]王双英,张 娜,刘 芳.具有高危复发因素的早期宫颈癌术后辅助治疗进展[J].医学信息,2018,31(15):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
WANG Shuang-ying,ZHANG Na,LIU Fang.Advances in Postoperative Adjuvant Therapy for Early Cervical Cancer with High Risk of Recurrence[J].Medical Information,2018,31(08):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]